Funding · Company
Vizgen, Inc.
Cambridge, MABiotech & Pharma
Vizgen, Inc. of Cambridge, MA has disclosed $241M across 3 Form D offerings filed with the SEC between May 5, 2022 and Jan 12, 2026.
$241M
Total disclosed
3
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$48M
Form D · Jan 12, 2026 ↗
Q1 2026
· target $50M
$85M
Form D · May 5, 2022 ↗
Q2 2022
· target $105M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001790415Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →